Cargando…
P07 BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD) IN REAL-LIFE MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANT: UPDATED ANALYSIS OF THE RANDOMIZED PHASE IV REAL MM TRIAL
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171484/ http://dx.doi.org/10.1097/01.HS9.0000936156.32733.12 |
| _version_ | 1785039426602139648 |
|---|---|
| author | Larocca, A. D’Agostino, M. Giuliani, N. Antonioli, E. Zambello, R. Ronconi, S. Vincelli, I. D. Ciceri, F. Falcone, A. P. Michieli, M. Cattel, F. Capra, A. Grasso, M. Cafro, A. M. Bonello, F. Floris, R. Offidani, M. Sciorsi, E. Pietrantuono, G. Curci, P. Patriarca, F. Cavo, M. Mangiacavalli, S. Benevolo, G. Evangelista, A. Ciccone, G. Boccadoro, M. Bruno, B. Bringhen, S. |
| author_facet | Larocca, A. D’Agostino, M. Giuliani, N. Antonioli, E. Zambello, R. Ronconi, S. Vincelli, I. D. Ciceri, F. Falcone, A. P. Michieli, M. Cattel, F. Capra, A. Grasso, M. Cafro, A. M. Bonello, F. Floris, R. Offidani, M. Sciorsi, E. Pietrantuono, G. Curci, P. Patriarca, F. Cavo, M. Mangiacavalli, S. Benevolo, G. Evangelista, A. Ciccone, G. Boccadoro, M. Bruno, B. Bringhen, S. |
| author_sort | Larocca, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10171484 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101714842023-05-11 P07 BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD) IN REAL-LIFE MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANT: UPDATED ANALYSIS OF THE RANDOMIZED PHASE IV REAL MM TRIAL Larocca, A. D’Agostino, M. Giuliani, N. Antonioli, E. Zambello, R. Ronconi, S. Vincelli, I. D. Ciceri, F. Falcone, A. P. Michieli, M. Cattel, F. Capra, A. Grasso, M. Cafro, A. M. Bonello, F. Floris, R. Offidani, M. Sciorsi, E. Pietrantuono, G. Curci, P. Patriarca, F. Cavo, M. Mangiacavalli, S. Benevolo, G. Evangelista, A. Ciccone, G. Boccadoro, M. Bruno, B. Bringhen, S. Hemasphere Poster Lippincott Williams & Wilkins 2023-05-09 /pmc/articles/PMC10171484/ http://dx.doi.org/10.1097/01.HS9.0000936156.32733.12 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Poster Larocca, A. D’Agostino, M. Giuliani, N. Antonioli, E. Zambello, R. Ronconi, S. Vincelli, I. D. Ciceri, F. Falcone, A. P. Michieli, M. Cattel, F. Capra, A. Grasso, M. Cafro, A. M. Bonello, F. Floris, R. Offidani, M. Sciorsi, E. Pietrantuono, G. Curci, P. Patriarca, F. Cavo, M. Mangiacavalli, S. Benevolo, G. Evangelista, A. Ciccone, G. Boccadoro, M. Bruno, B. Bringhen, S. P07 BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD) IN REAL-LIFE MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANT: UPDATED ANALYSIS OF THE RANDOMIZED PHASE IV REAL MM TRIAL |
| title | P07 BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD) IN REAL-LIFE MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANT: UPDATED ANALYSIS OF THE RANDOMIZED PHASE IV REAL MM TRIAL |
| title_full | P07 BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD) IN REAL-LIFE MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANT: UPDATED ANALYSIS OF THE RANDOMIZED PHASE IV REAL MM TRIAL |
| title_fullStr | P07 BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD) IN REAL-LIFE MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANT: UPDATED ANALYSIS OF THE RANDOMIZED PHASE IV REAL MM TRIAL |
| title_full_unstemmed | P07 BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD) IN REAL-LIFE MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANT: UPDATED ANALYSIS OF THE RANDOMIZED PHASE IV REAL MM TRIAL |
| title_short | P07 BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD) IN REAL-LIFE MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANT: UPDATED ANALYSIS OF THE RANDOMIZED PHASE IV REAL MM TRIAL |
| title_sort | p07 bortezomib-melphalan-prednisone (vmp) vs. lenalidomide-dexamethasone (rd) in real-life multiple myeloma patients ineligible for transplant: updated analysis of the randomized phase iv real mm trial |
| topic | Poster |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171484/ http://dx.doi.org/10.1097/01.HS9.0000936156.32733.12 |
| work_keys_str_mv | AT laroccaa p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT dagostinom p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT giulianin p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT antoniolie p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT zambellor p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT ronconis p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT vincelliid p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT cicerif p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT falconeap p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT michielim p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT cattelf p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT capraa p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT grassom p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT cafroam p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT bonellof p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT florisr p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT offidanim p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT sciorsie p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT pietrantuonog p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT curcip p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT patriarcaf p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT cavom p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT mangiacavallis p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT benevolog p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT evangelistaa p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT cicconeg p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT boccadorom p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT brunob p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial AT bringhens p07bortezomibmelphalanprednisonevmpvslenalidomidedexamethasonerdinreallifemultiplemyelomapatientsineligiblefortransplantupdatedanalysisoftherandomizedphaseivrealmmtrial |